NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
FDB MEDKNOWLEDGE EXPLORER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
FDB MEDKNOWLEDGE EXPLORER
ST13
US500000099072520Class
35, 44
Filing
99072520
Registration
8359558
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/21/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 44
Filing date
03/07/2025
Registration date
07/21/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/24/2025
First use in commerce
10/24/2025
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
MARCY, AMY ALFIERI
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
First Databank, Inc.
Representatives
David Michael Brioso The Hearst Corporation
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing an online computer database featuring consumer product information in the field of pharmaceuticals
Class 44
Providing an online computer database featuring medical information pertaining to administering medication and information pertaining to the diagnosticprophylactic and therapeutic properties of pharmaceuticals for the purpose of assisting and improving medication related decisions to enhance clinical care
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/17/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/17/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/17/2026
IUAF
USE AMENDMENT FILED
03/16/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/16/2026
EX1G
SOU EXTENSION 1 GRANTED
03/16/2026
EXT1
SOU EXTENSION 1 FILED
03/16/2026
EEXT
SOU TEAS EXTENSION RECEIVED
03/16/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/13/2026
PUBO
PUBLISHED FOR OPPOSITION
01/13/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/07/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2025
GNRT
NON-FINAL ACTION E-MAILED
09/13/2025
CNRT
NON-FINAL ACTION WRITTEN
09/13/2025
DOCK
ASSIGNED TO EXAMINER
08/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/07/2025
NWAP
NEW APPLICATION ENTERED
03/07/2025
Continuous trademark protection
Get notified about every new filing that threatens FDB MEDKNOWLEDGE EXPLORER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.